Regenity Overview
- Year Founded
-
1997
- Status
-
Private
- Employees
-
275
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
9
- Investments
-
2
Regenity General Information
Description
Manufacturer of collagen and mineral-based medical devices that support the body's natural ability to regenerate in areas such as tissue, bone, and nerve repair. The company produces collagen membranes for use in oral surgery, dental implants, bone defect, and ridge augmentation procedures and also conducts research and development in its laboratory and manufactures products for neurosurgery and orthopedic purposes, thereby delivering advanced devices and implants that support the body's natural ability to regenerate.
Contact Information
Website
www.regenity.comCorporate Office
- 115 West Century Road
- Suite 380
- Paramus, NJ 07652
- United States
Corporate Office
- 115 West Century Road
- Suite 380
- Paramus, NJ 07652
- United States
Regenity Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Regenity Comparisons
Industry
Financing
Details
Regenity Competitors (5)
One of Regenity’s 5 competitors is Viscus Biologics, a Accelerator/Incubator Backed company based in Cleveland, OH.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Viscus Biologics | Accelerator/Incubator Backed | Cleveland, OH | ||||
Reapplix | Venture Capital-Backed | Birkerod, Denmark | ||||
Encoll | Corporation | Fremont, CA | ||||
AB Dental Devices | Corporation | Ashdod, Israel | ||||
Dentsply Sirona | Formerly PE-Backed | Charlotte, NC |
Regenity Patents
Regenity Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023284939-A1 | Collagen-impregnated devices and methods for treatment of cancer | Pending | 06-Jun-2022 | ||
EP-4440530-A2 | Bioactive ceramics customized for tissue healing and methods for producing same | Pending | 29-Nov-2021 | ||
EP-4376854-A1 | Delivery system and methods for using same | Pending | 29-Jul-2021 | ||
US-20240325608-A1 | Delivery system and method for using same | Pending | 29-Jul-2021 | ||
EP-4337272-A1 | Flat self-curling sheet membranes and methods for producing same | Pending | 12-May-2021 | A61L27/46 |
Regenity Signals
Regenity Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Regenity Investments (2)
Regenity’s most recent deal was a Buyout/LBO with Polyganics. The deal was made on 30-Sep-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Polyganics | 30-Sep-2022 | Buyout/LBO | Surgical Devices | ||
Degradable Solutions | 29-Dec-2020 | Buyout/LBO | Therapeutic Devices |
Regenity FAQs
-
When was Regenity founded?
Regenity was founded in 1997.
-
Where is Regenity headquartered?
Regenity is headquartered in Paramus, NJ.
-
What is the size of Regenity?
Regenity has 275 total employees.
-
What industry is Regenity in?
Regenity’s primary industry is Other Devices and Supplies.
-
Is Regenity a private or public company?
Regenity is a Private company.
-
What is Regenity’s current revenue?
The current revenue for Regenity is
. -
Who are Regenity’s investors?
Acceleration International, Audax Private Equity, and Linden (Chicago) have invested in Regenity.
-
Who are Regenity’s competitors?
Viscus Biologics, Reapplix, Encoll, AB Dental Devices, and Dentsply Sirona are competitors of Regenity.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »